ClinConnect ClinConnect Logo
Search / Trial NCT04916106

Effect of Transcutaneous Electroacupuncture on Functional Abdominal Bloating/Distension

Launched by SECOND AFFILIATED HOSPITAL OF XI'AN JIAOTONG UNIVERSITY · Jun 3, 2021

Trial Information

Current as of May 29, 2025

Unknown status

Keywords

Functional Bloating/Distension Transcutaneous Electrical Acupoint Stimulation

ClinConnect Summary

Functional abdominal bloating/distension (FAB/D) is a common functional bowel disorder that lacks effective treatment options. Rome IV was introduced in 2016. Studies have shown that bloating may affect about 30% general population and 96% of patients with functional gastrointestinal disorders (FGID).Transcutaneous electroacupuncture (TEA) as a new therapeutic method has great effect on functional gastrointestinal diseases such as functional dyspepsia and functional constipation. Research on TEA for FAB/D has not yet been explored. Thirty patients who fulfilled the Rome IV diagnostic criter...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Clinical diagnosis of Functional bloating/distension with Rome IV;
  • 2. Aged 18-65 years old;
  • Exclusion Criteria:
  • 1. Have taken drugs that may affect gastrointestinal motility in the past week;
  • 2. Have taken antibiotics and probiotics in the past month;
  • 3. The history of gastrointestinal surgery;
  • 4. Helicobacter pylori is not cleared;
  • 5. Pregnant and breastfeeding women;
  • 6. Skin allergies.

About Second Affiliated Hospital Of Xi'an Jiaotong University

The Second Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution in China, dedicated to advancing healthcare through innovative clinical research and patient care. Affiliated with one of the country's premier universities, the hospital combines clinical excellence with academic rigor, fostering a multidisciplinary approach to healthcare challenges. With a strong emphasis on patient-centered care, the hospital engages in a wide range of clinical trials aimed at improving treatment outcomes and enhancing medical knowledge. Its commitment to ethical standards and regulatory compliance ensures that all research initiatives prioritize patient safety and scientific integrity.

Locations

Xi'an, Shaanxi, China

Xi'an, , China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials